Operating loss of BioNTech 2017-2019
In 2019, the annual operating loss of biotech company BioNTech SE was around 181.5 million euros, compared to around 53.9 million and 61.3 million euros in 2018 and 2017, respectively. This statistic illustrates the annual operating loss of BioNTech SE from 2017 to 2019, in thousand euros. On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.
